January 7, 2016Three research groups, working independently of one another, reported in the journal Science on Thursday that a powerful new gene-editing technique could treat Duchenne muscular dystrophy in mice.
Gall Named Associate Director of Duke MEDx
December 11, 2015Ken Gall has been appointed associate director of Duke MEDx. An interdisciplinary scientist whose work focuses on developing and understanding advanced materials for biomedical applications, Gall is a professor and chair of mechanical engineering and materials science in the Pratt School of [..]
Duke MEDx Announces 2015-2016 Colloquia Teams
November 11, 2015Duke MEDx is pleased to announce the results of its first RFA for interdisciplinary colloquia.
Trying a New Pulse for Pain Relief
October 28, 2015For people with incurable chronic pain, a small device that periodically stimulates the spinal cord with a small electric pulse can bring much needed relief. But the implantable devices don’t work for everyone. And when they do work, only about 60 percent of patients experience a halving of pain [..]
CRISPR Brings Precise Control to Gene Expression
October 26, 2015Researchers have demonstrated the exceptional specificity of a new way to switch sequences of the human genome on or off without editing the underlying genetic code. Originally discovered as an antiviral system in bacteria, CRISPR/Cas9 is one of the hottest topics in genetic research today. By [..]
October 14, 2015
August 28, 2015Four new projects and two renewal projects will receive nearly $800,000 for research through the 2015 Coulter-Duke Translational Partnership grant. The partnership supports collaborations between biomedical engineers and clinicians at Duke.
August 13, 2015
Ginsburg Named Director of New Pratt-School of Medicine Partnership
August 10, 2015Geoffrey Ginsburg, MD, PhD, has been named director of MEDx (Medicine and Engineering at Duke), leaders of the Duke University School of Medicine and Pratt School of Engineering announced on August 10. Ginsburg will serve for an initial three-year term.